Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
684,374
-
Share change
-
-195,480
-
Total reported value
-
$96,343,411
-
Put/Call ratio
-
27%
-
Price per share
-
$140.76
-
Number of holders
-
92
-
Value change
-
-$28,861,755
-
Number of buys
-
32
-
Number of sells
-
43
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q4 2018
As of 31 Dec 2018 ISHARES TR - U.S. PHARMA ETF (IHE) had 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 684,374 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, BROWN ADVISORY INC, COLONY GROUP LLC, BIEGEL & WALLER LLC, WELLS FARGO & COMPANY/MN, ROYAL BANK OF CANADA, AMERIPRISE FINANCIAL INC, BANK OF AMERICA CORP /DE/, MURPHY CAPITAL MANAGEMENT INC, and COMMONWEALTH EQUITY SERVICES, LLC.
This table shows 93 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.